Page last updated: 2024-08-24

atorvastatin and No-Reflow Phenomenon

atorvastatin has been researched along with No-Reflow Phenomenon in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Dong, H; Hu, X; Li, G; Liang, W; Lin, Y; Lu, H; Wang, W; Yu, B; Zhang, H; Zhou, L; Zhou, Y	1
Almeida-Gutierrez, E; Alonso-Bravo, RM; Borrayo-Sanchez, G; García-Méndez, RC; Isordia-Salas, I; Ortega-Ramirez, JA; Palomo-Villada, JA; Rosas-Peralta, M; Sánchez-Díaz, JS; Serrano-Cuevas, L	1
He, GX; Liu, XL; Xu, HP; Zhao, XJ	1
Doevendans, PA; Eefting, FD; Goumans, MJ; Post, MC; Post, S; Rensing, BJ; Stella, PR; van den Branden, BJ; van Es, HW; Wildbergh, TX	1

Trials

2 trial(s) available for atorvastatin and No-Reflow Phenomenon

Article	Year
Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction. Archives of medical research, 2018, Volume: 49, Issue:8 Topics: Adult; Aged; Angioplasty; Atorvastatin; C-Reactive Protein; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Preliminary Data; ST Elevation Myocardial Infarction; Survival Rate; Treatment Outcome	2018
Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Nov-01, Volume: 80, Issue:5 Topics: Aged; Atorvastatin; Biomarkers; Chi-Square Distribution; Coronary Circulation; Drug Administration Schedule; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardium; Netherlands; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Predictive Value of Tests; Pyrroles; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2012

Article

Year

Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction.

Archives of medical research, 2018, Volume: 49, Issue:8

Topics: Adult; Aged; Angioplasty; Atorvastatin; C-Reactive Protein; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Preliminary Data; ST Elevation Myocardial Infarction; Survival Rate; Treatment Outcome

2018

Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Nov-01, Volume: 80, Issue:5

Topics: Aged; Atorvastatin; Biomarkers; Chi-Square Distribution; Coronary Circulation; Drug Administration Schedule; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardium; Netherlands; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Predictive Value of Tests; Pyrroles; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling

2012

Other Studies

2 other study(ies) available for atorvastatin and No-Reflow Phenomenon

Article	Year
Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction. The Journal of international medical research, 2023, Volume: 51, Issue:6 Topics: Atorvastatin; Coronary Angiography; Coronary Circulation; Humans; Microcirculation; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Retrospective Studies; Rosuvastatin Calcium; ST Elevation Myocardial Infarction; Treatment Outcome	2023
Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2014, Volume: 47, Issue:3 Topics: Animals; Anticholesteremic Agents; Atorvastatin; Coronary Occlusion; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-6; Ligation; Male; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Necrosis; No-Reflow Phenomenon; Pyrroles; Rabbits; Random Allocation	2014

Article

Year

Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction.

The Journal of international medical research, 2023, Volume: 51, Issue:6

Topics: Atorvastatin; Coronary Angiography; Coronary Circulation; Humans; Microcirculation; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Retrospective Studies; Rosuvastatin Calcium; ST Elevation Myocardial Infarction; Treatment Outcome

2023

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2014, Volume: 47, Issue:3

Topics: Animals; Anticholesteremic Agents; Atorvastatin; Coronary Occlusion; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-6; Ligation; Male; Multivariate Analysis; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Necrosis; No-Reflow Phenomenon; Pyrroles; Rabbits; Random Allocation

2014